Floatz logo

Napazimone

Mitochondrial Respiratory Chain Deficiencies

Abliva ABSmall moleculePhase 1Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mitochondrial Respiratory Chain Deficiencies cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Napazimone is also rated in:

mitochondrial diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
MELAS syndromeDormant
CCC
Indicative ·
52 / 100
View asset →
inborn mitochondrial myopathyDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →